GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility.
Czepielewski RS, Jaeger N, Marques PE, Antunes MM, Rigo MM, Alvarenga DM, Pereira RV, da Silva RD, Lopes TG, da Silva VD, Porto BN, Menezes GB, Bonorino C.
Czepielewski RS, et al. Among authors: rigo mm.
Eur J Immunol. 2017 Apr;47(4):646-657. doi: 10.1002/eji.201646394.
Eur J Immunol. 2017.
PMID: 28294319
Free article.